Offerings - Eurocine Vaccines AB (publ) – Rights issue of SEK 15.6m
Arctic Securities is acting as financial advisor in relation to the 90 percent secured rights issue of SEK 15.6m for the Swedish listed vaccine company Eurocine Vaccines AB (publ). Eurocine Vaccines AB (publ) is referred to as “Eurocine Vaccines” or “the Company”. Shareholders have pre-emptive rights to subscribe for shares. Three (3) existing shares held on the record date of March 21, 2019, entitles to five (5) new shares. Subscription price of SEK 0.11 per share. The subscription period runs 25 March – 8 April, 2019. The rights issue is secured up to 90 percent through subscription- and guarantee undertakings. A Swedish memorandum and subscription note will be available before the subscription period on Eurocine Vaccines website, www.eurocine-vaccines.com and Arctic Securities website.